Printer Friendly

METHODIST HOSPITAL: NEW PROCEDURE ALLOWS DOCTORS TO VIEW FALLOPIAN TUBES; DIAGNOSTIC CAPABILITY COULD IMPROVE CLINICAL PREGNANCY RATES

 METHODIST HOSPITAL: NEW PROCEDURE ALLOWS DOCTORS TO VIEW FALLOPIAN
 TUBES; DIAGNOSTIC CAPABILITY COULD IMPROVE CLINICAL PREGNANCY RATES
 ST. LOUIS PARK, Minn., Nov. 2 /PRNewswire/ -- Until now, fallopian tubes have been difficult, if not impossible, to view inside a woman's body. However, a new diagnostic technique allows doctors to see the inside of a fallopian tube and detect abnormalities which could cause infertility or other problems.
 The procedure, called falloposcopy, will be utilized at Methodist Hospital, located in the Twin Cities. "For the first time, we will have a better understanding of fallopian tubes and can more accurately diagnose tubal disease. In infertile women, that means women will receive the most appropriate fertility treatments to achieve pregnancy," said Randle Corfman, Ph.D., M.D., a fertility specialist at Methodist Hospital who co-authored a scientific paper reporting the results of the clinical study.
 Results of the study, presented at the American Infertility Society's Annual Meeting in New Orleans Nov. 2-5, show that by using a falloposcope with a Linear Everting Catheter (LEC), a high degree of reliable image production was achieved safely and effectively. The FDA-approved clinical trial included 92 women, 57 of which were infertile. In 80 percent of the cases, successful visualization was achieved and several abnormalities were detected, which in come cases, lead to altering the course of treatment.
 Hysterosalpingogram (HSG) to detect abnormalities in the reproductive tract, which only reveals shadows and is less effective than the LEC falloposcope system (Imagyn Medical, Inc., San Clemente, Calif.), Corfman said.
 Corfman recently left the Mayo Clinic to open The Midwest Center for Reproductive Health in St. Louis Park, at Methodist Hospital. The center specializes in the treatment of infertility and women's health, through a network of satellites in the Upper Midwest, including Minneapolis, and rural parts of Minnesota, North Dakota, South Dakota, Montana, Wisconsin and Ontario, Canada.
 Methodist will be one of only a few institutions in the country offering the LEC falloposcope procedure. "Providing people with access to high-tech reproductive services is key. At the center, we've established contacts with over 20 satellite physician offices so that our patients' care can be managed close to home," Corfman said. "That's what makes reproductive endocrinology services at the center and at Methodist Hospital unique," he said.
 Methodist Hospital, St. Louis Park, is a 426-bed acute care, not-for-profit hospital serving Minneapolis and the western suburbs with specialties in five areas: Maternity Care, Cardiac Care, Emergency Services, Cancer Care and Rehabilitation Services.
 -0- 11/2/92
 /EDITORS: Corfman available for interviews via telephone in New Orleans. Call Methodist Hospital to arrange/
 /CONTACT: Judith Brenner of Methodist Hospital, 612-932-6057/ CO: Methodist Hospital ST: Minnesota IN: HEA SU:


DM -- MN003 -- 7530 11/02/92 08:02 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 2, 1992
Words:452
Previous Article:PHILIPS, READER'S DIGEST SIGN CD-I PACT
Next Article:PERRIGO COMPANY OF SOUTH CAROLINA, INC. ANNOUNCES PLANT EXPANSION, 35 NEW JOBS CREATED BY 1993
Topics:


Related Articles
ABBOTT LABORATORIES MEETS CHALLENGES OF LABORATORY MEDICINE WITH NEW THIRD-GENERATION INSTRUMENT
PROSTATE CANCER AND MALE INFERTILITY FOCUS OF BROAD PRODUCT OFFERINGS FROM ACUSON CORPORATION
CONCEPTUS, INC. RECEIVES FDA CLEARANCE FOR TRANSCERVICAL FALLOPIAN TUBE CATHETERIZATION
CONCEPTUS, MALLINCKRODT ANNOUNCE MARKETING PARTNERSHIP IN THE AMERICAS
Hysteroscopic sterilization widens patient options. (Rapid Patient Recovery).
Conceptus Announces FDA Approval of Three-year Effectiveness Claim for Essure.
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System.
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable.
Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System.
Contraception system wins approval.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters